REPL

Replimune Group Inc

NASDAQ · Biotechnology

$7.75

+0.82 (+11.83%)

Small-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks

Analyst Consensus

Strong Buy

14 analysts

Buy 11 79%

Hold 3 21%

Sell 0 0%

Price Target

Analyst Price Target +358.7% upside

Low Target $27.68

Average Target $35.55

High Target $47.36

Current Price $7.75

Current
$7.75

Target
$35.55

$27.68 $35.55 avg $47.36